Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03267134 · ClinicalTrials.gov registry record · NA
Hydrus Microstent for Refractory Open-Angle Glaucoma
A NA study, sponsored by Ivantis.
- Completed
- Registry status
- NA
- Development phase
- 217
- Enrollment target
NCT03267134 is a NA study that has completed, run by Ivantis. The registered enrollment target is 217 participants.
The verdict
NCT03267134, a NA study, has completed, sponsored by Ivantis.
- COMPLETED
- Registry status
- NA
- Development phase
- 217 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and effectiveness of the Hydrus Microstent in patients with refractory open-angle glaucoma.
Interventions
- DEVICE Hydrus Microstent
- PROCEDURE Ophthalmic surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2022-12-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03267134
The ClinicalTrials.gov registry entry for NCT03267134 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 217 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ivantis, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydrus Microstent is the first listed.
NCT03267134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03267134 about?
NCT03267134 is a clinical study titled "Hydrus Microstent for Refractory Open-Angle Glaucoma". The purpose of this study is to assess the safety and effectiveness of the Hydrus Microstent in patients with refractory open-angle glaucoma.
What is the current status of trial NCT03267134?
This trial is currently completed. It is a NA study. The enrollment target is 217 participants. The study started on 2017-08-01. Estimated completion is 2022-12-16.
What interventions are being tested in trial NCT03267134?
The interventions under investigation include: Hydrus Microstent (DEVICE), Ophthalmic surgery (PROCEDURE).
Who is sponsoring clinical trial NCT03267134?
This trial is sponsored by Ivantis, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.